Pharmaron Beijing Co., Ltd. (03759) Announces October 2025 Share Capital and Movements Update

Bulletin Express

Nov 05

Pharmaron Beijing Co., Ltd. (03759) disclosed that, as of October 31, 2025, the authorized share capital consisted of 301,537,125 H shares (par value RMB 1) and 1,476,658,400 A shares (par value RMB 1), totaling RMB 1,778,195,525. There were no changes in the number of authorized or issued shares for both H and A shares within the month.

The report indicated 301,537,125 H shares issued, of which 7,263,300 were held in treasury. These treasury shares remain designated for the 2025 H Share Award and Trust Scheme, approved on June 20, 2025. The 1,476,658,400 A shares showed no movement in treasury during the period.

Pharmaron Beijing Co., Ltd. continues to manage several A share incentive schemes adopted in recent years, although no new A shares were issued or transferred out of treasury during the reporting period. By the end of October 2025, the company reported no changes in its total issued share capital or treasury shareholdings.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1183254795"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183254795\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183254795?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 17:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183254795","market":"hk","top_or_hot":-1,"title":"Pharmaron Beijing Co., Ltd. (03759) Announces October 2025 Share Capital and Movements Update","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. (03759) disclosed that, as of October 31, 2025, the authorized share capital consisted of 301,537,125 H shares (par value RMB 1) and 1,476,658,400 A shares (par value RMB 1), totaling RMB 1,778,195,525. There were no changes in the number of authorized or issued shares for both H and A shares within the month.</p>\n<p>The report indicated 301,537,125 H shares issued, of which 7,263,300 were held in treasury. These treasury shares remain designated for the 2025 H Share Award and Trust Scheme, approved on June 20, 2025. The 1,476,658,400 A shares showed no movement in treasury during the period.</p>\n<p>Pharmaron Beijing Co., Ltd. continues to manage several A share incentive schemes adopted in recent years, although no new A shares were issued or transferred out of treasury during the reporting period. By the end of October 2025, the company reported no changes in its total issued share capital or treasury shareholdings.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Beijing Co., Ltd. (03759) Announces October 2025 Share Capital and Movements Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Beijing Co., Ltd. (03759) Announces October 2025 Share Capital and Movements Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-05 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. (03759) disclosed that, as of October 31, 2025, the authorized share capital consisted of 301,537,125 H shares (par value RMB 1) and 1,476,658,400 A shares (par value RMB 1), totaling RMB 1,778,195,525. There were no changes in the number of authorized or issued shares for both H and A shares within the month.</p>\n<p>The report indicated 301,537,125 H shares issued, of which 7,263,300 were held in treasury. These treasury shares remain designated for the 2025 H Share Award and Trust Scheme, approved on June 20, 2025. The 1,476,658,400 A shares showed no movement in treasury during the period.</p>\n<p>Pharmaron Beijing Co., Ltd. continues to manage several A share incentive schemes adopted in recent years, although no new A shares were issued or transferred out of treasury during the reporting period. By the end of October 2025, the company reported no changes in its total issued share capital or treasury shareholdings.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1183254795","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183254795","pubTimestamp":1762334544,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. (03759) disclosed that, as of October 31, 2025, the authorized share capital consisted of 301,537,125 H shares (par value RMB 1) and 1,476,658,400 A shares (par value RMB...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成（北京）股份有限公司(03759)公布2025年10月股本及变动更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. (03759) disclosed that, as of October 31, 2025, the authorized share capital consisted of 301,537,125 H shares (par value RMB 1) and 1,476,658,400 A shares (par value RMB 1), totaling RMB 1,778,195,525. There were no changes in the number of authorized or issued shares for both H and A shares within the month.\nThe report indicated 301,537,125 H shares issued, of which 7,263,300 were held in treasury. These treasury shares remain designated for the 2025 H Share Award and Trust Scheme, approved on June 20, 2025. The 1,476,658,400 A shares showed no movement in treasury during the period.\nPharmaron Beijing Co., Ltd. continues to manage several A share incentive schemes adopted in recent years, although no new A shares were issued or transferred out of treasury during the reporting period. By the end of October 2025, the company reported no changes in its total issued share capital or treasury shareholdings.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}